Molina Healthcare Inc vs Merck & Company, Inc. — Stock Comparison
Molina Healthcare Inc (MOH) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. clearly outscores Molina Healthcare Inc on Q·Score (6.9 vs 4.8 out of 10), led by Growth (6.2 vs 1.7) and Quality (7.7 vs 4.6). Molina Healthcare Inc scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for MRK (+7.6%) than for MOH (+5.6%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Valuation metrics in line with sector peers.
⚠ revenue declining 4% year-over-year.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MOH vs MRK: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.9/10 versus Molina Healthcare Inc (MOH) at 4.8/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MOH or MRK?
Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 1.7/10). Molina Healthcare Inc reports revenue growth (-4.3% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MOH or MRK more attractively valued?
Molina Healthcare Inc (MOH) scores higher on Valuation (7.7/10 vs 6.4/10). MOH trades at 19.3× P/E versus MRK at 12.6×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MOH vs MRK?
There are 16 analysts covering MOH with a consensus price target of $186.63, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MOH or MRK?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 4.6/10). Net profit margin: MOH at 0.4%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MOH or MRK?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.1/10). Market beta: MOH at 0.85, MRK at 0.20. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MOH and MRK?
Molina Healthcare Inc (MOH) has a market capitalisation of $9.2B, while Merck & Company, Inc. (MRK) has a market cap of $297.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MOH or MRK pay dividends?
MOH does not currently pay a dividend, while MRK pays a dividend yield of 2.83%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →